Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-05-31

FDA Approved: GLIMEPIRIDE — Supplemental Application (Solco Healthcare U.S., LLC)

View source ↗

Summary

The FDA approved a supplemental application for Solco Healthcare U.S., LLC to market a generic version of glimepiride. Glimepiride is used to improve glycemic c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)

Snippet

SUPPL AP for GLIMEPIRIDE (GLIMEPIRIDE)